MedTrace Logo

Biomarkers in Samples From Young Patients With Neuroblastoma

NCT01358604 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2016-04-15

No results posted yet for this study

Summary

RATIONALE: Studying samples of tissue and bone marrow from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research study studies biomarkers in samples from young patients with neuroblastoma.

Conditions

Interventions

GENETIC

polymerase chain reaction

GENETIC

protein expression analysis

GENETIC

western blotting

OTHER

flow cytometry

OTHER

immunohistochemistry staining method

OTHER

laboratory biomarker analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Children's Oncology Group

    lead NETWORK

Principal Investigators

  • David Hema, MD, MPH · NCI - Experimental Transplantation and Immunology Branch

Eligibility

Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2016-04-30
Completion
2016-04-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01358604 on ClinicalTrials.gov